Live Breaking News & Updates on Safety Run In Cohorts

Stay updated with breaking news from Safety run in cohorts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Teclistamab Triplet Shows Manageable Safety, Early Efficacy in Transplant-Ineligible Myeloma

Teclistamab plus daratumumab and lenalidomide had a manageable safety profile in patients with transplant-ineligible, newly diagnosed multiple myeloma. ....

United States , Teclistamab Tecvayli , Salomon Manier , American Society For Transplantation , Lille University Hospital , International Myeloma Working Group , Common Terminology Criteria , Adverse Events , American Society , Cellular Therapy , Safety Run In Cohorts ,